Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

α-Spinasterol-3-O-β-D-glucoside

α-Spinasterol-3-O-β-D-glucoside is a sterol glucoside that can be isolated from the seeds of Momordica cochinchinensis[1].

Product Specifications

CAS Number

1745-36-4

Product Name Alternative

α-Spinasterol glucoside

UNSPSC

12352005

Target

Others

Type

Natural Products

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/α-spinasterol-3-o-β-d-glucoside.html

Solubility

10 mM in DMSO

Smiles

C[C@@]12[C@](CC[C@]2([H])[C@H](C)/C=C/[C@@H](CC)C(C)C)([H])C3=CC[C@](C[C@H](CC4)O[C@@H]5O[C@@H]([C@H]([C@@H]([C@H]5O)O)O)CO)([H])[C@@]4(C)[C@@]3([H])CC1

Molecular Formula

C35H58O6

Molecular Weight

574.83

References & Citations

[1]Zheng MS, et al. Chemical constituents of Melandrium firmum Rohrbach and their anti-inflammatory activity. Arch Pharm Res. 2008 Mar;31 (3) :318-22.

Shipping Conditions

Room temperature

Scientific Category

Natural Products

Clinical Information

No Development Reported

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Recombinant CCL4 Antibody
RC-16129-01 50 μL

Recombinant CCL4 Antibody

Sign In for Pricing
View Details
Recombinant CCL4 Antibody
RC-16129-02 100 µL

Recombinant CCL4 Antibody

Sign In for Pricing
View Details
Recombinant CCL4 Antibody
RC-16129-03 1 mL

Recombinant CCL4 Antibody

Sign In for Pricing
View Details
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2784), CF405S conjugate, 0.1mg/mL
BNC042784-500 1x 500 µL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2784), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
sec-Butylbenzene
TRC-B692705-1G 1 g

sec-Butylbenzene

Sign In for Pricing
View Details
Mouse Ccnt1 activation kit by CRISPRa
GA200589 1 Kit

Mouse Ccnt1 activation kit by CRISPRa

Sign In for Pricing
View Details